RaySearch Laboratories AB announces that the National Cancer Centre Singapore has placed an order for RayStation®* as the treatment planning system for its new proton therapy center currently under construction and scheduled for completion by 2022.
RaySearch Laboratories AB (publ) announces that the National Cancer Centre Singapore (NCCS) has placed an order for RayStation®* as the treatment planning system for its new proton therapy center currently under construction and scheduled for completion by 2022.
STOCKHOLM, Sept. 23, 2021 /PRNewswire/ -- NCCS provides a holistic, multi-disciplinary approach to cancer treatment and patient care, and sees close to 65 percent of Singapore’s public sector oncology cases.
The Goh Cheng Liang Proton Therapy Centre at NCCS will be equipped with the state-of-the-art PROBEAT treatment delivery system from Hitachi. The setup will include four treatment gantries capable of 360° rotation and a fixed-beam room.
Hitachi’s treatment delivery system includes dose driven continuous scanning (DDCS) functionality - an innovative technique aimed at improving proton dose delivery accuracy. RayStation is currently the only treatment planning system to support DDCS.
In addition to manual planning licences for pencil beam scanning, the RayStation installation will also include machine learning capabilities for both segmentation and automatic planning.
Johan Löf, founder and CEO, RaySearch, says: “We are proud to be part of NCCS:s new and advanced proton therapy investment, which will benefit patients in Singapore. Techniques such as DDCS are pushing the frontiers of radiation therapy, and it is a priority for us to incorporate the latest developments. We are committed to ensuring that RayStation is the most compatible treatment planning system, leading the way in supporting the latest clinical advances.”
The total order value is about 2.7 MEUR, including a five-year service contract.
For more information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
johan.lof@raysearchlabs.com
Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59
peter.thysell@raysearchlabs.com
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
| RaySearch press release final NCCS 23 Sept 2021 | |
| https://news.cision.com/raysearch-laboratories/i/pr-nccs-1200x620,c2958720 | PR NCCS 1200x620 |
View original content:https://www.prnewswire.com/news-releases/national-cancer-centre-singapore-selects-raystation-for-new-proton-center-301383765.html
SOURCE RaySearch Laboratories
Company Codes: Bloomberg:RAYB@SS, ISIN:SE0000135485, RICS:RAYB.ST, Stockholm:RAY-B
